Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Loxo Oncology Inc (NASDAQ:LOXO)

27.32
Delayed Data
As of May 25
 +0.86 / +3.25%
Today’s Change
11.11
Today|||52-Week Range
35.00
-3.97%
Year-to-Date
No recent news for Loxo Oncology Inc.

Today’s Trading

Previous close26.46
Today’s open26.65
Day’s range26.31 - 27.37
Volume102,800
Average volume (3 months)139,967
Market cap$565.3M
Dividend yield--
Data as of 05/25/2016

Growth & Valuation

Earnings growth (last year)+30.72%
Earnings growth (this year)-12.39%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.35

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...+0.15+0.77%
SCMPSucampo Pharmaceutic...-0.07-0.59%
XNCRXencor Inc+0.30+2.26%
CLVSClovis Oncology Inc+0.42+2.70%
Data as of 4:00pm ET, 05/25/2016

Financials

Next reporting dateSeptember 9, 2016
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$0.00
Annual profit (last year)-$35.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Josh Bilenker
Executive Director-
Business Operations
Sara Slifka
Corporate headquarters
Stamford, Connecticut

Forecasts

Partner Offers

Search for Jobs